A new vaccine trial for stable mets patients, including brain mets, will be opening at University of Washington hopefully by this fall. It will be a DNA vaccine, as opposed to the CTL vaccine which I'm receiving, but the great advantage is that one need NOT be HLA-A2 positive, so more of us will qualify for this one. I think concurrent Herceptin is required, but contact Patty Fintak for more info: (206)543-6620.
|